EV/EBITDA
-93.29
+2.95+3.07%
12 min ago
Summary
- As of February 7, 2025, BPMC EV/EBITDA is -93.29, with a rise of +2.95 (+3.07%) during the most recent trading day.
- BPMC EV/EBITDA is now -578.90% below its all-time high of 19.48.
Performance
BPMC EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
BPMC EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +3.1% | -3.1% | -3.2% |
| 1 m1 month | -9.3% | +9.3% | +9.9% |
| 3 m3 months | -1.8% | +1.8% | +1.9% |
| 6 m6 months | -143.4% | +15.2% | +16.6% |
| ytdytd | -18.6% | +18.6% | +19.9% |
| 1 y1 year | - | +40.4% | +34.8% |
| 5 y5 years | -906.4% | +113.5% | +70.7% |
BPMC EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -18.8% | -102.24 | +8.8% | |
| 3 m | 3-month | -78.38 | -19.0% | -102.24 | +8.8% |
| 6 m | 6-month | -36.14 | -158.1% | -102.24 | +8.8% |
| 1 y | 1-year | -11.68 | -698.7% | -102.24 | +8.8% |
| 3 y | 3-year | -3.45 | -2604.1% | -102.24 | +8.8% |
| 5 y | 5-year | 19.48 | -578.9% | -102.24 | +8.8% |
| alltime | all time | 19.48 | -578.9% | -102.24 | +8.8% |
Blueprint Medicines EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -93.29(+18.6%) |
| 2024 | -78.63(+1475.8%) |
| 2022 | -4.99(-49.1%) |
| 2021 | -9.81(-152.5%) |
| 2020 | 18.67(-269.1%) |
| Date | Value |
|---|---|
| 2019 | -11.04(+15.5%) |
| 2018 | -9.56(-50.7%) |
| 2017 | -19.40(+54.5%) |
| 2016 | -12.56(+14.4%) |
| 2015 | -10.98 |
FAQ
- What is Blueprint Medicines EV/EBITDA?
- What is the all time high EV/EBITDA for Blueprint Medicines?
- What is BPMC EV/EBITDA year-to-date change?
What is Blueprint Medicines EV/EBITDA?
The current EV/EBITDA of BPMC is -93.29
What is the all time high EV/EBITDA for Blueprint Medicines?
Blueprint Medicines all-time high EV/EBITDA is 19.48
What is BPMC EV/EBITDA year-to-date change?
Blueprint Medicines EV/EBITDA has changed by -14.66 (-18.64%) since the beginning of the year